Intervention Protocol

You have free access to this content

Postoperative adjuvant transarterial (chemo)embolisation after liver resection for hepatocellular carcinoma

  1. Qi Zhang1,
  2. Xue Li Bai1,
  3. Wei Chen1,
  4. Tao Ma1,
  5. Hao Liu1,
  6. Yun Zhang1,
  7. Xiao Jun Hu2,
  8. Ting Bo Liang1,*

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 23 DEC 2013

DOI: 10.1002/14651858.CD010897


How to Cite

Zhang Q, Bai XL, Chen W, Ma T, Liu H, Zhang Y, Hu XJ, Liang TB. Postoperative adjuvant transarterial (chemo)embolisation after liver resection for hepatocellular carcinoma (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 12. Art. No.: CD010897. DOI: 10.1002/14651858.CD010897.

Author Information

  1. 1

    the Second Affiliated Hospital, School of Medicine, Zhejiang University, Department of Hepatobiliary and Pancreatic Surgery, Hangzhou, Zhejiang Province, China

  2. 2

    Zhejiang University, Center for Medical Information, Hangzhou, China

*Ting Bo Liang, Department of Hepatobiliary and Pancreatic Surgery, the Second Affiliated Hospital, School of Medicine, Zhejiang University, 88 Jiefang Road, Hangzhou, Zhejiang Province, 310009, China. liangtingbo@zju.edu.cn.

Publication History

  1. Publication Status: New
  2. Published Online: 23 DEC 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate systematically the available literature of randomised clinical trials regarding the benefits and harms of transarterial (chemo)embolisation as a postoperative adjuvant treatment in people who have undergone hepatectomy for hepatocellular carcinoma.